Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.

Journal article

Goodwin GM. et al, (2023), Neuropsychopharmacology

Must Psilocybin Always "Assist Psychotherapy"?

Journal article

Goodwin GM. et al, (2023), Am J Psychiatry

Psilocybin for Treatment-Resistant Depression. Reply.

Journal article

Goodwin GM. et al, (2023), N Engl J Med, 388

Unblinding and demand characteristics in the treatment of depression.

Journal article

Goodwin GM. et al, (2023), J Affect Disord, 328, 1 - 5

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.

Journal article

Goodwin GM. et al, (2022), N Engl J Med, 387, 1637 - 1648

Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.

Journal article

Thomas CW. et al, (2022), Transl Psychiatry, 12

The costs of bipolar disorder in the United Kingdom.

Journal article

Simon J. et al, (2021), Brain Behav, 11

Generalised Anxiety Disorder and Depression: Contemporary Treatment Approaches.

Journal article

Goodwin GM. and Stein DJ., (2021), Adv Ther

Load More